Biology of Blood and Marrow Transplantation
Volume 13, Issue 3 , Pages 263-264 , March 2007

Hematopoietic Progenitor Cell Transplantation in 2007: New Challenges and New Opportunities for the Center for International Blood and Marrow Transplant Research

  • Sergio Giralt

      Affiliations

    • Corresponding Author InformationCorrespondence and reprint requests: Sergio Giralt, MD, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

Received 10 August 2006 ,Accepted 15 December 2006.

References 

  1. Barnes DWH, Corp MJ, Loutit JF, Neal FE. Treatment of murine leukaemia with X-rays and homologous bone marrow (Preliminary communication). Br Med J. 1956;2:626
  2. Thomas ED, Buckner CD, Banaji M, et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood. 1977;49:511
  3. Mughal TI, Goldman JM. Chronic myeloid leukemia: current status and controversies. Oncology (Huntington). 2004;18:837–844847
  4. Loberiza FR, Zhang MJ, Lee SJ, et al. Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. Blood. 2005;105:2979–2987
  5. Loberiza FR, Serna DS, Horowitz MM, Rizzo JD. Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?. Bone Marrow Transplant. 2003;31:417–421

PII: S1083-8791(06)01308-5

doi: 10.1016/j.bbmt.2006.12.444

Biology of Blood and Marrow Transplantation
Volume 13, Issue 3 , Pages 263-264 , March 2007

Article Tools